Clinical Trials - Phase II
Filter News
Found 29,657 articles
-
Viamet Pharmaceuticals Expands Phase 2 Clinical Program With Novel Antifungal Agent VT-1161
9/24/2013
-
BioLineRx Ltd. Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
9/24/2013
-
Neurovance Announces FDA Acceptance of IND Application For EB-1020 SR and Initiates Phase 2a Study in Adult ADHD
9/24/2013
-
Lightlake Therapeutics Inc. Commences Two-Week Patient Trial for Treatment of Opioid Overdose With National Institute on Drug Abuse (NIDA)
9/24/2013
-
Edison Pharmaceuticals, Inc. Announces Initiation of National Institutes of Health (NIH)-Sponsored EPI-743 Clinical Trial With NIH Undiagnosed Diseases Program Patients
9/24/2013
-
Isis Pharmaceuticals, Inc. Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients With Familial Chylomicronemia
9/23/2013
-
Alexion Pharmaceuticals Inc. Release: New Data Evaluating Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP) Presented at Paediatric Endocrinology Meeting
9/23/2013
-
Isis Pharmaceuticals, Inc. to Conduct Webcast and Conference Call to Discuss ISIS-APOCIII Rx Phase 2 Data
9/23/2013
-
Boehringer Ingelheim Corporation's Volasertib Wins FDA Breakthrough Therapy Designation
9/20/2013
-
Cyclacel Pharmaceuticals, Inc.'s Sapacitabine Reported to Have Anti-Tumor Activity Against Ovarian Cancer
9/20/2013
-
Prima Biomed's Ovarian Cancer Treatment Shows No Difference in Phase 2 Study
9/19/2013
-
Omeros Corporation Reports Initiation of Phase 2 Clinical Trial With OMS824
9/19/2013
-
Mesoblast Limited's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference
9/19/2013
-
Viralytics Ltd Meets Primary Endpoint in CAVATAK Phase 2 Melanoma Trial
9/18/2013
-
Creabilis SA Announces Treatment of First Patients in its Phase 2b Trial of CT327 in Pruritus in Atopic Dermatitis Patients
9/18/2013
-
NeoStem, Inc. Reports Third Data Safety Monitoring Board Review of PreSERVE AMI Trial
9/17/2013
-
Aptiv Solutions Launches ADDPLAN® DF for Optimizing Dose Selection in Phase 2 Trials
9/17/2013
-
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Reports Positive Follow-on Phase 2 Results for Brain Cancer Vaccine in Newly Diagnosed Patients
9/17/2013
-
Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting
9/17/2013
-
FDA Lifts Clinical Hold of Pluristem Therapeutics's Phase 2 Intermittent Claudication Study
9/16/2013